ZNF704 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.834200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.887600E-01
Normal-vs-Stage2
7.272800E-01
Normal-vs-Stage3
4.526400E-01
Normal-vs-Stage4
4.232000E-01
Stage1-vs-Stage2
8.105400E-01
Stage1-vs-Stage3
3.216000E-01
Stage1-vs-Stage4
1.723610E-01
Stage2-vs-Stage3
3.799000E-01
Stage2-vs-Stage4
3.833900E-02
Stage3-vs-Stage4
7.675700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.323000E-01
Normal-vs-AfricanAmerican
7.133200E-01
Normal-vs-Asian
5.666600E-01
Caucasian-vs-AfricanAmerican
1.045820E-01
Caucasian-vs-Asian
5.358600E-01
AfricanAmerican-vs-Asian
2.025200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.370600E-01
Normal-vs-Female
7.472400E-01
Male-vs-Female
6.972400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.001000E-01
Normal-vs-Age(41-60Yrs)
9.488600E-01
Normal-vs-Age(61-80Yrs)
5.162600E-01
Normal-vs-Age(81-100Yrs)
4.701400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.997000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.996800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.712180E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.165800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.064460E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.183590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.689400E-01
Normal-vs-Daily Drinker
5.698800E-01
Normal-vs-Weekly Drinker
3.060400E-01
Normal-vs-Occasional Drinker
6.933800E-01
Normal-vs-Social Drinker
9.797200E-01
Non Drinker-vs-Daily Drinker
1.818820E-01
Non Drinker-vs-Weekly Drinker
2.515000E-01
Non Drinker-vs-Occasional Drinker
9.655000E-01
Non Drinker-vs-Social Drinker
5.153000E-01
Daily Drinker-vs-Weekly Drinker
9.530400E-01
Daily Drinker-vs-Occasional Drinker
1.926820E-01
Daily Drinker-vs-Social Drinker
1.637010E-01
Weekly Drinker-vs-Occasional Drinker
2.581600E-01
Weekly Drinker-vs-Social Drinker
1.731830E-01
Occasional Drinker-vs-Social Drinker
5.294600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.768580E-01
Normal-vs-Grade 2
1.141200E-01
Normal-vs-Grade 3
6.217900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.790400E-01
Grade 1-vs-Grade 3
3.996800E-01
Grade 1-vs-Grade 4
1.768580E-01
Grade 2-vs-Grade 3
8.538800E-01
Grade 2-vs-Grade 4
1.141200E-01
Grade 3-vs-Grade 4
6.217900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.298800E-01
Normal-vs-NonDiabetic
5.482000E-01
Diabetic-vs-NonDiabetic
8.043600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.223400E-01
Normal-vs-NoPancreatitis
6.145400E-01
Pancreatitis-vs-NoPancreatitis
2.927800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.529800E-01
Normal-vs-N1
7.780600E-01
N0-vs-N1
2.875800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.784200E-01
Normal-vs-TP53-NonMutant
9.254000E-01
TP53-Mutant-vs-TP53-NonMutant
5.631000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
